Hypofractionated radiotherapy (66Gy at 3Gy per fraction) for favorable-risk prostate cancer: Long-term outcomes.
Nita Patel
No relevant relationships to disclose
Sergio Faria
No relevant relationships to disclose
Fabio L. Cury
No relevant relationships to disclose
Marc David
No relevant relationships to disclose
Marie Duclos
No relevant relationships to disclose
George Shenouda
No relevant relationships to disclose
Luis Souhami
No relevant relationships to disclose